- Free from Publisher F Chiarelli, F Cipollone, A Mohn, M Marini, A … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We studied 30 patients with type 1 diabetes (15
with and 15 without microalbuminuria) compared with matched healthy control
subjects. Plasma MCP-1 and plasma oxidant status (vitamin E, fluorescent ... Cited by 46 - Related articles - BL Direct - All 6 versions
T Morii, H Fujita, T Narita, T Shimotomai, H … - Journal of diabetes and its complications, 2003 - Elsevier Monocyte chemoattractant protein-1 (MCP-1), is a chemokine that mediates renal
interstitial inflammation, tubular atrophy, and interstitial fibrosis by
recruiting monocytes/macrophages into renal tubulointerstitium. Recent ... Cited by 61 - Related articles - All 9 versions
S Kiyici, E Erturk, F Budak, C Ersoy, E Tuncel … - Archives of medical research, 2006 - Elsevier Monocyte chemoattractant protein (MCP)-1 is suggested to be implicated in the
pathogenesis of diabetic nephropathy by activating and recruiting monocytes to
the glomerulus via regulation of adhesion molecule expressions. The aim of ... Cited by 21 - Related articles - All 14 versions
N Banba, T Nakamura, M Matsumura, H Kuroda, … - Kidney international, 2000 - nature.com Monocyte chemoattractant protein-1 (MCP-1) is a specific chemokine to recruit
and activate monocytes from the circulation to inflammatory site. In diabetic
nephropathy, similar to other glomerulonephropathies, infiltration and ... Cited by 159 - Related articles - BL Direct - All 6 versions
K Takebayashi, S Matsumoto, Y Aso, T Inukai - Journal of Diabetes and its Complications, 2006 - Elsevier In 70 nonobese inpatients with Type 2 diabetes [body mass index (BMI): 24.0±4.4
kg/m 2 ], we examined circulating monocyte chemoattractant protein (MCP) -1 as a
candidate marker of atherosclerosis by comparison with established markers: ... Cited by 18 - Related articles - All 15 versions
K Tashiro, I Koyanagi, A Saitoh, A Shimizu, T … - Journal of clinical laboratory analysis, 2002 - interscience.wiley.com We examined the correlation among the levels of urinary monocyte chemoattractant
protein-1 (MCP-1) and interleukin-8 (IL-8), hyperglycemia, and renal injuries in
patients with type 2 diabetic nephropathy. The levels of urinary MCP-1, ... Cited by 42 - Related articles - BL Direct - All 5 versions
FY Chow, DJ Nikolic-Paterson, E Ozols, RC … - Kidney international, 2006 - nature.com Diabetic nephropathy involves a renal inflammatory response induced by the
diabetic milieu. Macrophages accumulate in diabetic kidneys in association with
the local upregulation of monocyte chemoattractant protein-1 (MCP-1); ... Cited by 76 - Related articles - BL Direct - All 3 versions
E El-Shafey, GF El-Nagar, HA Hatab, A Sabry, … - syrexe.com 1 Department of Nephrology, Faculty of Medicine, Tanta University, Gharbia,
Egypt 2 Department of Internal Medicine, Faculty of Medicine, Tanta University,
Gharbia, Egypt 3 Urology and Nephrology Center, Mansoura University, ... Related articles - View as HTML
P Martín-Gallán, A Carrascosa, M Gussinye, … - Free radical research, 2005 - informahealthcare.com Abstract Increased oxidative stress has emerged as a potential mechanism
implicated in the pathogenesis, progression and cell dysfunction associated with
many diseases including diabetes. In routine clinical practice, the ... Cited by 20 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org B Amann, R Tinzmann, B Angelkort - Diabetes Care, 2003 - Am Diabetes Assoc OBJECTIVE—Chemokines play an important role in the pathogenesis of diabetic
nephropathy. Angiotensin II induces several fibrogenic chemokines, namely
monocyte chemoattractant protein-1 (MCP-1) and transforming growth ... Cited by 71 - Related articles - BL Direct - All 5 versions
